Market Tracker

04/23 12:05pm ET
30.67
Real-Time Quote
 -0.16 / -0.52%
Today’s Change
8.87
Today|||52-Week Range
38.73
+108.21%
Year-to-Date

Today’s Trading

Previous close30.83
Today’s open30.94
Day’s range29.41 - 30.95
Volume712,937
Average volume (3 months)3,576,310
Market cap$2.8B
Dividend yield--
Data as of 11:49am ET, 04/23/2014

Growth & Valuation

Earnings growth (last year)-17.39%
Earnings growth (this year)+8.26%
Earnings growth (next 5 years)+60.00%
Revenue growth (last year)+168.74%
P/E ratioNM
Price/Sales17.04
Price/Book19.25

Competitors

 Today’s
change
Today’s
% change
GEVASynageva BioPharma C...+0.36+0.43%
XONIntrexon Corp-1.01-4.79%
AEGRAegerion Pharmaceuti...-0.66-1.46%
IMGNImmunoGen Inc-0.63-4.33%
Data as of 12:03pm ET, 04/23/2014

Financials

Next reporting dateMay 1, 2014
EPS forecast (this quarter)-$0.62
Annual revenue (last year)$70.3M
Annual profit (last year)-$219.6M
Net profit margin-313.88%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Daniel G. Welch
Executive VP, Chief Financial &
Accounting Officer
John C. Hodgman
Corporate headquarters
Brisbane, California

Forecasts